A Clinical Study to Check the Safety and Effectiveness of Botanical Extract Standardized for Iron + Vitamin c and Botanical Extract Standardized for Iron in Adult Human Subjects With Anemia or Iron-deficiency Anemia

Anemia, Iron Deficiency Clinical Trial

Official title:
A Randomized, Double-blind, Parallel, Three-arms, Placebo-controlled, Safety and Efficacy Study of Botanical Extract Standardized for Iron + Vitamin C and Botanical Extract Standardized for Iron in Adult Human Subjects With Anemia or Iron-deficiency Anemia

Status Not yet recruiting

Clinical Trial Summary

A randomized, double-blind, parallel, three-arms, placebo-controlled, safety and efficacy study of Botanical Extract Standardized for Iron + Vitamin C and Botanical Extract Standardized for Iron in adult human subjects with anemia or iron-deficiency anemia. A total of up to 96 adult male and female subjects of age 26 to 55 years (32 subjects/arm) will be enrolled to get 90 evaluable subjects (30 subjects/arm) in the study

Clinical Trial Description

The potential subjects will be screened as per the inclusion & exclusion criteria only after obtaining written informed consent from the subjects. The adult female/male subjects will be instructed to visit the facility as per the below visits. There will be total of 4 visits in this study. - Visit 01 (Within 30 Days): Screening procedure, informed consent obtain process, baseline evaluations, blood collection, urine collection. - Visit 02 (Day 01): Enrolment, randomization, product distribution, subject diary distribution, blood collection. - Visit 03 (Day 30 ± 2 Days): Treatment period, blood collection, evaluations, consumer's QoL product perception questionnaire, subject diary review, AE reporting (if any). - Visit 04 (Day 60 ± 2 Days): End of study process, evaluation, blood collection, urine collection, consumer's QoL and product perception questionnaire, subject diary collection, test treatments accountability, AE reporting (if any). Assessment of efficacy parameters before test treatment usage will be done on screening visit within 30 days of Day 01, on Day 01 and after test treatment usage will be done on Day 30 (± 2 Days) and Day 60 (± 2 Days). Blood Parameter Analysis: Hemoglobin, Hematocrit, RBC, WBC, MCV, MCH, MCHC, Serum Iron, Serum ferritin, Transferrin, Transferrin Saturation, Total Iron Binding Capacity, Total Cholesterol, Triglycerides, Random Glucose, Serum Creatinine, Uric Acid, SGPT, SGOT, LDL, HDL, HBsAG, SOD. Urine Parameter: Chemical Parameters - Albumin, Blood, Glucose, pH; Physcial Parameters - Colour, Appearance and Deposits. QoL Product Perception: Fatigue, Mood, Sleepiness, GI Discomfort, Energy Level, Epigastric Discomfort, Nausea, Diarrhoea, Constipation ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06096103
Study type	Interventional
Source	NovoBliss Research Pvt Ltd
Contact	Maheshvari N Patel
Phone	9909013236
Email	maheshvari@novobliss.in
Status	Not yet recruiting
Phase	N/A
Start date	November 15, 2023
Completion date	January 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04435574` - Lactoferrin for Treatment of Iron Deficiency Anemia.	Phase 4
Not yet recruiting	`NCT05467319` - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS	Phase 3
Not yet recruiting	`NCT05050851` - Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt
Recruiting	`NCT04278651` - Early Antenatal Support for Iron Deficiency Anemia	Phase 4
Recruiting	`NCT04626414` - Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers	Phase 1
Withdrawn	`NCT03800446` - Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood	N/A
Recruiting	`NCT05304442` - IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department	Phase 3
Enrolling by invitation	`NCT03897673` - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas	N/A
Completed	`NCT05047211` - Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia	Phase 4
Not yet recruiting	`NCT06061393` - Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia	Phase 4
Completed	`NCT05190263` - Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma
Completed	`NCT03318055` - Prevalence of Hyperglycemia and Anaemia in Elective Surgical Patients
Completed	`NCT04631679` - Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)
Recruiting	`NCT05225545` - Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis	Phase 3
Recruiting	`NCT03347513` - Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?	Phase 4
Recruiting	`NCT04708665` - Iron Deficiency Anemia and Non-iron Deficiency Anemia in Pregnancy in India
Completed	`NCT02404012` - Iron Supplement to Improve Iron Status Following Bariatric Surgery	N/A
Completed	`NCT04137354` - Iron and Vitamin A in School Children	N/A
Completed	`NCT03156712` - Iron Absorption From Iron-enriched Aspergillus Oryzae	N/A
Completed	`NCT05522790` - Impact of Iron Infusion in Anemic Patients on Their Postoperative Outcome After Colorectal Surgery